Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative.
about
Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 20142014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2Use of High-Frequency In-Home Monitoring Data May Reduce Sample Sizes Needed in Clinical Trials.Enrichment and stratification for predementia Alzheimer disease clinical trials.Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer diseaseMeasuring brain atrophy with a generalized formulation of the boundary shift integral.Sensitivity to change and prediction of global change for the Alzheimer's QuestionnaireImaging-based enrichment criteria using deep learning algorithms for efficient clinical trials in mild cognitive impairmentAlzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.Advances in designs for Alzheimer's disease clinical trials.Five-year biomarker progression variability for Alzheimer's disease dementia prediction: Can a complex instrumental activities of daily living marker fill in the gaps?Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial.Choosing Alzheimer's disease prevention clinical trial populations.Alzheimer's disease drug development: translational neuroscience strategies.Systematic review of strengths and limitations of randomized controlled trials for non-pharmacological interventions in mild cognitive impairment: focus on Alzheimer's disease.Optimizing Effect Sizes With Imaging Enrichment and Outcome Choices for Mild Alzheimer Disease Clinical Trials.The effect of diagnostic criteria on outcome measures in preclinical and prodromal Alzheimer's disease: Implications for trial design.Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer's disease.The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review.The importance of endpoint selection: How effective does a drug need to be for success in a clinical trial of a possible Alzheimer's disease treatment?Gender Differences in Elderly With Subjective Cognitive Decline.Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future.
P2860
Q26801629-5C7C888F-64D6-4F4E-B25B-3701262BE60AQ30971403-A6C18A77-83D8-404F-A54F-1A8F9A62FC54Q30981669-78C9DC05-26FA-4F22-A1D3-FBD259C8145AQ30994007-400E1AB6-FCBE-488E-9665-F0014E9E97B9Q34452239-01E8BEC4-2D77-4A5E-9CBC-CC6484C514CBQ34620948-C838B153-68D5-4D58-9031-C5B17F50EE01Q34889037-D2122F75-791B-4688-8E8A-02A02E66F2A3Q36298580-09DB31F4-8870-4A18-A253-0FF525FDCE33Q36385288-340EADD8-BF02-4CD0-83F2-9F89F2C71233Q36574825-9E5EFCAD-0D15-4D41-B4CF-1DDF1FD74437Q36576472-07A2EFE9-C7A0-4345-A965-4A9ECF42291EQ36933700-6D59EA0E-2979-4BE5-BE16-0CDD596ED20BQ37364862-D7667FD3-C524-4DAE-9745-215DF64B385BQ37395823-8F073953-667D-4B3E-8822-3EA69B4C39D7Q38087640-5BF55D38-6266-4313-B8BF-6411E503C264Q38344080-C2E1897A-5734-4446-87AF-7F0695FA96BDQ39753296-91D36ACE-6113-44A9-9198-AB449A3F9B1FQ47134402-B060FF44-1D2A-404A-826E-5422C2D22D5BQ49357063-6F5A5607-1690-4532-83EE-D7AA554BF6DDQ52585260-BB417A70-BA8D-4916-B96A-6FCB844896FCQ54249538-1D35136B-3257-4D97-BCAD-BE74402DADC8Q55238739-44B9D99D-913D-470A-9A25-007F731F0B01Q55364364-E961C675-F5CA-42EE-8378-3CDAF8F89C08
P2860
Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Estimating sample sizes for pr ...... sease Neuroimaging Initiative.
@ast
Estimating sample sizes for pr ...... sease Neuroimaging Initiative.
@en
type
label
Estimating sample sizes for pr ...... sease Neuroimaging Initiative.
@ast
Estimating sample sizes for pr ...... sease Neuroimaging Initiative.
@en
prefLabel
Estimating sample sizes for pr ...... sease Neuroimaging Initiative.
@ast
Estimating sample sizes for pr ...... sease Neuroimaging Initiative.
@en
P2093
P2860
P50
P921
P1476
Estimating sample sizes for pr ...... sease Neuroimaging Initiative.
@en
P2093
David Elashoff
John Ringman
Joshua D Grill
Liana G Apostolova
Nicole Chow
Omid Kohannim
P2860
P356
10.1016/J.NEUROBIOLAGING.2012.03.006
P577
2012-04-13T00:00:00Z